OCT embedded sections of pathological specimens as a source of high quality RNA for reverse transcriptase/polymerase chain reaction.
Authors:
- G CainGCG Cain
- A ParrAPA Parr
- M HowardMHM Howard
- B AngusBAB Angus
- A R CattanACA R Cattan
Open Access
- 1 March 1996
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 49 (3) , 258-259
Abstract
OCT embedded cryostat sections of stored pathological specimens of non-Hodgkin's lymphoma were used to provide RNA. After reverse transcription to produce cDNA, the polymerase chain reaction was performed with primers for standard and variant forms of the CD44 molecule. Using Southern transfer and hybridisation with a probe specific for exon 4 of the CD44 gene, both standard and variant forms were visualised by autoradiography. This method was shown to be applicable to other gene products by using primers specific for the abl and bcr genes. This technique permits retrospective analysis of RNA from small amounts of stored pathological samples.Keywords
This publication has 10 references indexed in Scilit:
- CD44 variant exon epitopes in primary breast cancer and length of survivalThe Lancet, 1995
- Comparison of immunohistochemistry and RT‐PCR for detection of CD44v‐expression, a new prognostic factor in human breast cancerInternational Journal of Cancer, 1995
- CD44 isoforms during differentiation and developmentBioEssays, 1995
- An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders.1994
- Expression and modulation of CD44 variant isoforms in humansJournal of Cell Biology, 1994
- Minimal Residual Disease after Bone Marrow Transplant for Chronic Myeloid Leukaemia Detected by the Polymerase Chain ReactionLeukemia & Lymphoma, 1993
- CD44 and its role in tumour progression and metastasisEuropean Journal of Cancer, 1993
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.Proceedings of the National Academy of Sciences, 1992
- Significance of CD44 gene products for cancer diagnosis and disease evaluationThe Lancet, 1992
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979